Healthcare teams should treat pentesting as part of continuous vulnerability management, not a one-time event. The goal is to find exploitable paths across applications, APIs, devices, and internal systems before adversaries do. Strategic testing should also validate segmentation and trust boundaries, because one weak point can expose patient data or interrupt care delivery across the broader network.
How pentesting should be scoped in healthcare environments
Healthcare pentesting is most useful when it mirrors the paths ransomware operators actually use, rather than stopping at a single application or flat network assumption. That means testing the routes that connect EHR systems, remote access, APIs, medical device segments, and administrative tooling, so teams can see whether one compromise can spread into a care-impacting event. A practical scope also includes segmentation controls, credential pathways, and the systems that mediate trust between clinical and IT domains.
A useful way to frame the exercise is to test for CISA cyber threat advisories-style ransomware conditions, then validate whether the organisation’s architecture actually blocks those paths. If a tester can pivot from a user workstation into a shared service, a management plane, or a device network, that is a sign the real-world blast radius is too large.
When healthcare teams want a control reference for the same problem, the ISO/IEC 27002:2022 Information Security Controls control set is useful because it links testing, access control, logging, and configuration management into a single operating model. That matters in clinical environments where the weakest connected component is often not the best-known system, but the one with the least visibility.
Where ransomware paths usually appear across connected systems and devices
The highest-value findings usually come from exposure chains, not isolated misconfigurations. Common examples include weak segmentation between corporate and clinical networks, broad administrative credentials, exposed remote services, overly trusted APIs, and medical device environments that were built for availability but not for hostile lateral movement. Pentesting should deliberately try to cross those boundaries, because the purpose is to show where trust is too broad for the actual risk profile.
This is also where device and software baseline hardening becomes relevant. If a test reveals that a device or support system is reachable with default services, weak management access, or legacy protocol trust, that finding is more important than a simple checklist miss. The CIS Benchmarks are useful here because they give teams a concrete hardening reference for operating systems, databases, cloud services, and network devices that often sit in the attack path.
Healthcare teams should also pay close attention to externally facing dependencies such as remote support, integration middleware, and API layers. Those components can turn a narrow foothold into broad access if authentication, privilege boundaries, or segmentation assumptions are weaker than expected. The NIST Cybersecurity Framework 2.0 is a good top-level way to organise that work because it forces teams to connect testing outcomes to governance, protection, detection, response, and recovery rather than treating pentest results as one-off tickets.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
CIS Controls v8, NIST CSF 2.0 and NIST SP 800-63 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| CIS Controls v8 | CIS 4 — Secure Configuration of Enterprise Assets and Software | Healthcare pentesting should validate hardening on connected systems and devices. |
| CIS 5 — Account Management | Ransomware paths often depend on overbroad or stale access that pentesting can expose. | |
| CIS 12 — Network Infrastructure Management | Segmentation and trust boundaries are central to testing ransomware spread paths. | |
| Recommendation — Validate and enforce hardened baselines on exposed systems, devices, and management planes. Review privileged and shared accounts for excessive access and remove unnecessary rights. Test and manage network boundaries so lateral movement between segments is constrained. | ||
| NIST CSF 2.0 | PR.AC-4 — Access Permissions and Authorizations | Pentesting should verify that access paths do not allow unauthorized reach across systems. |
| PR.PT-4 — Communications and Control Networks Protected | Healthcare segmentation testing maps directly to protecting control and communication paths. | |
| DE.CM-8 — Vulnerability Scans Are Performed | Pentesting complements ongoing vulnerability discovery across the connected environment. | |
| Recommendation — Limit access permissions so a foothold cannot expand into broader system reach. Protect control and communication networks with segmentation and boundary enforcement. Combine scanning and testing to continuously identify exploitable exposure paths. | ||
| NIST SP 800-63 | IAL-2 — Identity Proofing, Level 2 | Administrative and remote access paths in healthcare rely on trustworthy identity assurance. |
| AAL-2 — Authenticator Assurance Level 2 | Ransomware operators often exploit weak authentication on connected management and remote access. | |
| FAL-2 — Federation Assurance Level 2 | Connected healthcare environments often depend on federated trust across systems and vendors. | |
| Recommendation — Use stronger identity assurance for access paths that could reach sensitive clinical assets. Require stronger authenticators for systems whose compromise would enable lateral movement. Constrain federation trust so external assertions cannot overreach into internal systems. | ||
Practitioner Guidance
What to prioritise: Start with pathways that could interrupt care or encrypt shared dependencies, not with the easiest external-facing web app. In healthcare, the highest-value test is usually the one that proves whether one compromised segment can reach identity services, management interfaces, backup systems, or device-support infrastructure.
What to verify: Make sure the report does more than list vulnerabilities. It should show whether segmentation held, whether privilege boundaries held, and whether the team can prove the path was blocked after remediation. If a finding cannot be traced to a specific lateral movement or escalation path, it is probably not yet described at the right depth for ransomware defence.
What good looks like: A strong programme produces retests that confirm broken attack chains, not just patched findings. Teams should be able to demonstrate that an initial foothold no longer reaches clinical systems, that remote access is constrained, and that device networks are not silently trusted by broader enterprise administration.
Practitioner takeaway: For healthcare, pentesting reduces ransomware risk only when it is used to validate real containment, not to count vulnerabilities. The key question is whether the organisation can stop a single compromise from becoming a cross-system operational event.
Related resources from NHI Mgmt Group
- How should healthcare security teams reduce identity risk on legacy medical devices that cannot support MFA?
- How should security teams reduce the risk of password reuse across systems?
- How should security teams reduce risk when IT tools are spread across many systems?
- How should healthcare security teams move beyond periodic pentesting to reduce breach risk in clinical environments?
